|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Sauer AG, Fedewa SA,
Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal A:
Colorectal cancer statistics, 2020. CA Cancer J Clin. 70:145–164.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Song Y, Yang Y, Gao P, Chen X, Yu D, Xu Y,
Zhao J and Wang Z: The preoperative neutrophil to lymphocyte ratio
is a superior indicator of prognosis compared with other
inflammatory biomarkers in resectable colorectal cancer. BMC
Cancer. 17:7442017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan D, Fu Y, Tong W and Li F: Prognostic
significance of lymphocyte to monocyte ratio in colorectal cancer:
A meta-analysis. Int J Surg. 55:128–138. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takada K, Kashiwagi S, Asano Y, Goto W,
Ishihara S, Morisaki T, Shibutani M, Tanaka H, Hirakawa K and Ohira
M: Clinical verification of body mass index and tumor immune
response in patients with breast cancer receiving preoperative
chemotherapy. BMC Cancer. 21:11292021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zamorano AS, Hagemann AR, Morrison L, Lee
JA, Liao LM, Brinton LA, Park Y and Toriola AT: Pre-diagnosis body
mass index, physical activity and ovarian cancer mortality. Gynecol
Oncol. 155:105–111. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang P, Li Y, Sun H, Liu S, Zhang R, Liu X
and Zhu Z: Predictive value of body mass index for short-term
outcomes of patients with esophageal cancer after esophagectomy: A
meta-analysis. Ann Surg Oncol. 26:2090–2103. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shukla S, Babcock Z, Pizzi L and Brunetti
L: Impact of body mass index on survival and serious adverse events
in advanced non-small cell lung cancer treated with bevacizumab: A
meta-analysis of randomized clinical trials. Curr Med Res Opin.
37:811–817. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye Z, Wei S, Zeng Y, Wang Y, Lin Z, Chen
S, Xie Y, Zheng Q and Chen L: Prognostic value of preoperative body
mass index for diabetic patients with non-metastasis gastric
cancer: A single center experience. BMC Surg. 21:3202021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee S, Lee DH, Lee JH, Shin SJ, Lee HS,
Park EJ, Baik SH, Lee KY and Kang J: Association of body mass index
with survival in Asian patients with colorectal cancer. Cancer Res
Treat. 54:860–872. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chiu CC, Ho CH, Hung CM, Chao CM, Lai CC,
Chen CM, Liao KM, Wang JJ, Wu YC, Shi HY, et al: Correlation of
body mass index with oncologic outcomes in colorectal cancer
patients: A large population-based study. Cancers. 13:35922021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song N, Huang D, Jang D, Kim MJ, Jeong SY,
Shin A and Park JW: Optimal body mass index cut-off point for
predicting colorectal cancer survival in an asian population: A
national health information database analysis. Cancers (Basel).
12:8302020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guercio BJ, Zhang S, Venook AP, Ou FS,
Niedzwiecki D, Lenz HJ, Innocenti F, Mullen BC, O'Neil BH, Shaw JE,
et al: Body mass index and weight loss in metastatic colorectal
cancer in CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr.
4:pkaa0242020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwak HD, Ju JK, Kang DW, Baek SJ, Kwak JM,
Kim J and Kim SH: Outcomes according to body mass index following
laparoscopic surgery in patients with colorectal cancer. J Minim
Access Surg. 14:134–139. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dragomir R, Dragomir AS, Negru A, Săftescu
S, Popovici D, Schenker M, Lupușoru R and Negru Ș: Role of
combining neutrophil-to-lymphocyte ratio and pretreatment body mass
index in predicting progression-free survival in patients with
non-small cell lung cancer treated with nivolumab. Exp Ther Med.
21:5262021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu YY, Chang KP, Lin CY, Pai PC, Wang HM,
Hsu CL, Liao CT, Yen TC, Fang TJ, Huang SF, et al: Prognostic
significance of combined pretreatment lymphocyte counts and body
mass index in patients with head and neck cancer treated with
radiation therapy. Cancer Med. 7:2808–2815. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Locker GY, Hamilton S, Harris J, Jessup
JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF and Bast RC Jr:
ASCO 2006 update of recommendations for the use of tumor markers in
gastrointestinal cancer. J Clin Onol. 24:5313–5327. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thirunavukarasu P, Sukumar S, Sathaiah M,
Mahan M, Pragatheeshwar KD, Pingpank JF, Zeh H III, Bartels CJ, Lee
KKW and Bartlett DL: C-stage in colon cancer: implications of
carcinoembryonic antigen biomarker in staging, prognosis, and
management. J Natl Cancer Inst. 103:689–697. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carriquiry LA and Piñeyro A: Should
carcinoembryonic antigen be used in the management of patients with
colorectal cancer? Dis Colon Rectum. 42:921–929. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ailawadhi S, Sunga A, Rajput A, Yang GY,
Smith J and Fakih M: Chemotherapy-induced carcinoembryonic antigen
surge in patients with metastatic colorectal cancer. Oncology.
70:49–53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang CS, Chen CY, Huang LK, Wang WS and
Yang SH: Postoperative serum carcinoembryonic antigen levels cannot
predict survival in colorectal cancer patients with type II
diabetes. J Chin Med Assoc. 83:911–917. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang CS, Chen CY, Huang LK, Wang WS and
Yang SH: Prognostic value of postoperative serum carcinoembryonic
antigen levels in colorectal cancer patients who smoke. PLoS One.
15:e02336872020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kacel EL, Kirsch JL, Sannes TS, Patidar S,
Postupack R, Jensen S, Wong S, Garey S, Dodd S, Ulfig CM, et al:
Interleukin-6 and body mass index, tobacco use, and sleep in
gynecologic cancers. Health Psychol. 38:866–877. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Khaodhiar L, Ling PR, Blackburn GL and
Bistrian BR: Serum levels of interleukin-6 and C-reactive protein
correlate with body mass index across the broad range of obesity.
JPEN J Parenter Enteral Nutr. 28:410–415. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ullmann CD, Schlom J and Greiner JW:
Interleukin-6 increases carcinoembryonic antigen and
histocompatibility leukocyte antigen expression on the surface of
human colorectal carcinoma cells. J Immunother (1991). 12:231–241.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Belluco C, Nitti D, Frantz M, Toppan P,
Basso D, Plebani M, Lise M and Jessup JM: Interleukin-6 blood level
is associated with circulating carcinoembryonic antigen and
prognosis in patients with colorectal cancer. Ann Surg Oncol.
7:133–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bullen AW, Losowsky MS, Carter S, Patel S
and Neville AM: Diagnostic usefulness of plasma carcinoembryonic
antigen levels in acute and chronic liver disease.
Gastroenterology. 73:673–678. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang CS, Huang LK, Chen CY, Wang WS and
Yang SH: Prognostic value of postoperative serum carcinoembryonic
antigen levels in colorectal cancer patients with chronic kidney
disease. Am J Surg. 221:162–167. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
MacGregor TP, Maughan TS and Sharma RA:
Pathological grading of regression following neoadjuvant
chemoradiation therapy: The clinical need is now. J Clin Pathol.
65:867–871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu R, You YJ, Li F and Yan B:
Postoperative fasting blood glucose predicts prognosis in stage
I–III colorectal cancer patients undergoing resection.
Gastroenterol Res Prac. 2020:24824092020.PubMed/NCBI
|
|
31
|
Zhang YC, Liu Y, Qiu XM and Yan B:
Concurrent comparison of the prognostic values of tumor budding,
tumor stroma ratio, tumor infiltrating pattern and
lymphocyte-to-monocyte ratio in colorectal cancer patients. Technol
Cancer Res Treat. 20:153303382110458262021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Zhao R, Cui Y, Zhou Y and Wu X: The
dynamic change of neutrophil to lymphocyte ratio can predict
clinical outcome in stage I–III colon cancer. Sci Rep. 8:94532018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie H, Huang S, Yuan G, Tang S and Gan J:
Prognostic significance of preoperative fibrinogen-to-prealbumin
ratio in patients with stage I–III colorectal cancer undergoing
surgical resection: A retrospective cohort study. Biomed Res Int.
2021:39053532021.PubMed/NCBI
|
|
34
|
DeLong ER, DeLong DM and Clarke-Pearson
DL: Comparing the areas under two or more correlated receiver
operating characteristic curves: A nonparametric approach.
Biometrics. 44:837–845. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Beom SH, Shin SJ, Kim CG, Kim JH, Hur H,
Min BS, Lee KY, Kim NK and Ahn JB: Clinical significance of
preoperative serum carcinoembryonic antigen within the normal range
in colorectal cancer patients undergoing curative resection. Ann
Surg Oncol. 27:2774–2783. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cai Z, Xiao J, He X, Ke J, Zou Y, Chen Y,
Wu X, Li X, Wang L, Wang J, et al: Accessing new prognostic
significance of preoperative carcinoembryonic antigen in colorectal
cancer receiving tumor resection: More than positive and negative.
Cancer Biomark. 19:161–168. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Z, Zhang Y, Niu Y, Li K, Liu X, Chen H
and Gao C: A systematic review and meta-analysis of diagnostic and
prognostic serum biomarkers of colorectal cancer. PLoS One.
9:e1039102014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tumay V and Guner OS: The utility and
prognostic value of CA 19-9 and CEA serum markers in the long-term
follow up of patients with colorectal cancer. A single-center
experience over 13 years. Ann Ital Chir. 91:494–503.
2020.PubMed/NCBI
|
|
39
|
Björkman K, Mustonen H, Kaprio T, Kekki H,
Pettersson K, Haglund C and Böckelman C: CA125: A superior
prognostic biomarker for colorectal cancer compared to CEA, CA19-9
or CA242. Tumour Biol. 43:57–70. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Iacuzzo C, Germani P, Troian M, Mis TC,
Giudici F, Osenda E, Bortul M and de Manzini N: Serum
carcinoembryonic antigen pre-operative level in colorectal cancer:
Revisiting risk stratification. ANZ J Surg. 91:E367–E374. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li X, Xiong Z, Xie M, Huang Q, Jin L, Yin
S, Chen S, Lan P and Lian L: Prognostic value of the ratio of
carcinoembryonic antigen concentration to maximum tumor diameter in
patients with stage II colorectal cancer. J Gastrointest Oncol.
12:1470–1481. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xie W, Huang X, Wei C, Mo X, Ru H, Zhang
L, Ge L, Tang W and Liu J: Preoperative neutrophil-BMI ratio as a
promising new marker for predicting tumor outcomes in colorectal
cancer. Technol Cancer Res Treat. Feb 28–2022.(Epub ahead of
print). View Article : Google Scholar
|
|
43
|
Baqar AR, Wilkins S, Staples M, Lee CH,
Oliva K and McMurrick P: The role of preoperative CEA in the
management of colorectal cancer: A cohort study from two cancer
centres. Int J Surg. 64:10–15. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gold P and Freedman SO: Demonstration of
tumor-specific antigens in huamn colonic carcinoma by immunological
tolerance and absorption techniques. J Exp Med. 121:439–462. 1965.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Goldstein MJ and Mitchell EP:
Carcinoembryonic antigen in the staging and follow-up of patients
with colorectal cancer. Cancer Invest. 23:338–351. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bajenova O, Gorbunova A, Evsyukov I, Rayko
M, Gapon S, Bozhokina E, Shishkin A and O'Brien SJ: The genome-wide
analysis of carcinoembryonic antigen signaling by colorectal cancer
cells using RNA sequencing. PLoS One. 11:e01612562016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huang EY, Chang JC, Chen HH, Hsu CY, Hsu
HC and Wu KL: Carcinoembryonic antigen as a marker of
radioresistance in colorectal cancer: A potential role of
macrophages. BMC Cancer. 18:3212018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lee J, Meyerhardt JA, Giovannucci E and
Jeon JY: Association between body mass index and prognosis of
colorectal cancer: A meta-analysis of prospective cohort studies.
PLoS One. 10:e01207062015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Daniel CR, Shu X, Ye Y, Gu J, Raju GS,
Kopetz S and Wu X: Severe obesity prior to diagnosis limits
survival in colorectal cancer patients evaluated at a large cancer
centre. Br J Cancer. 114:103–109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Meier CR, Krähenbühl S, Schlienger RG and
Jick H: Association between body mass index and liver disorders: An
epidemiological study. J Hepatol. 37:741–747. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Salvaggio A, Periti M, Miano L, Tavanelli
M and Marzorati D: Body mass index and liver enzyme activity in
serum. Clin Chem. 37:720–723. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jessup JM, Laguinge L, Lin S, Samara R,
Aufman K, Battle P, Frantz M, Edmiston KH and Thomas P:
Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits
hepatic ischemic/reperfusion injury to colorectal carcinoma cells.
Int J Cancer. 111:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Han J, Meng Q, Shen L and Wu G:
Interleukin-6 induces fat loss in cancer cachexia by promoting
white adipose tissue lipolysis and browning. Lipids Health Dis.
17:142018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Carson JA and Baltgalvis KA: Interleukin 6
as a key regulator of muscle mass during cachexia. Exerc Sport Sci
Rev. 38:168–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Webster JM, Kempen LJAP, Hardy RS and
Langen RCJ: Inflammation and skeletal muscle wasting during
cachexia. Front Physiol. 11:5976752020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lino-Silva LS, Anchondo-Nunez P,
Chit-Huerta A, Aguilar-Romero E, Morales-Soto J, Salazar-Garcia JA,
Guzman-Lopez CJ, Maldonado-Martinez HA, Meneses-Garcia A and
Salcedo-Hernández RA: Stage I–III colon cancer patients with tumor
deposits behave similarly to stage IV patients. Cross-section
analysis of 392 patients. J Surg Oncol. 120:300–307.
2019.PubMed/NCBI
|
|
58
|
Moon JY, Lee MR and Ha GW: Prognostic
value of tumor deposits for long-term oncologic outcomes in
patients with stage III colorectal cancer: A systematic review and
meta-analysis. Int J Colorectal Dis. 37:141–151. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Naszai M, Kurjan A and Maughan TS: The
prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio
(NLR) in colorectal cancer: A systematic review and meta-analysis.
Cancer Med. 10:5983–5997. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gkekas I, Novotny J, Fabian P, Nemecek R,
Palmqvist R, Strigard K, Pecen L, Svoboda T, Gurlich R and
Gunnarsson U: Deficient mismatch repair as a prognostic marker in
stage II colon cancer patients. Eur J Surg Oncol. 45:1854–1861.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang B, Li F, Zhou X, Ma Y and Fu W: Is
microsatellite instability-high really a favorable prognostic
factor for advanced colorectal cancer? A meta-analysis. World J
Surg Oncol. 17:1692019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Le DT, Uram JN, Wang H, Bartlett BR,
Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et
al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl
J Med. 372:2509–2520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Flaherty DC, Jalas JR, Sim MS,
Stojadinovic A, Protic M, Lee DJ and Bilchik AJ: The negative
impact of body mass index on the tumor microenvironment in colon
cancer: Results of a prospective trial. Ann Surg Oncol.
25:1374–1380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Søreide K, Søreide JA and Kørner H:
Prognostic role of carcinoembryonic antigen is influenced by
microsatellite instability genotype and stage in locally advanced
colorectal cancers. World J Surg. 35:888–894. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
André T, Boni C, Mounedji-Boudiaf L,
Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan
P, Bridgewater J, et al: Oxaliplatin, fluorouracil, and leucovorin
as adjuvant treatment for colon cancer. N Engl J Med.
350:2343–2345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
André T, Meyerhardt J, Iveson T, Sobrero
A, Yoshino T, Souglakos I, Grothey A, Niedzwiecki D, Saunders M,
Labianca R, et al: Effect of duration of adjuvant chemotherapy for
patients with stage III colon cancer (IDEA collaboration): final
results from a prospective, pooled analysis of six randomised,
phase 3 trials. Lancet Oncol. 21:1620–1629. 2020. View Article : Google Scholar : PubMed/NCBI
|
